Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin vs Routine Care for Hemodynamic Stability in Preeclampsia C-Section
NCT06107335Phase 4Not yet recruiting
- Sponsor
- UTHealth Houston
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in preeclampsia, sponsored by UTHealth Houston. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06107335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06107335.